Informação sobre produto
CDDO-EA is a synthetic compound that is being studied for its potential as an anti-cancer therapy. This agent has shown to have growth factor-β1 response elements and can be used as an experimental model for proton irradiation. CDDO-EA has been shown to work by inhibiting the production of reactive oxygen species that are produced in response to oxidative injury, which may lead to cancer. CDDO-EA also promotes the development of the M2 phenotype, which suppresses tumor growth and causes myeloid-derived suppressors (MDS) cells to develop in a tumor microenvironment. These cells produce cytokines that promote an anti-tumor immune response.
Propriedades químicas
Consulta técnica sobre: 3D-HMB73051 CDDO-EA
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
